You are currently viewing a new version of our website. To view the old version click .

Innovative Drug Release and Vaccine Delivery Systems

This special issue belongs to the section “Drug Delivery and Controlled Release“.

Special Issue Information

Dear Colleagues,

We are pleased to invite you to contribute to the Special Issue entitled “Innovative Drug Release and Vaccine Delivery Systems”, which aims to highlight recent advances in the field. Drug delivery research is a multidisciplinary effort ranging from basic science to clinical trials, aiming to develop advanced therapies for acute and chronic illnesses. Different approaches have been taken to improve drugs’ pharmacological profile, and to provide targeted and increased bioavailability. In addition, nanomaterials and nanotechnologies, as well as various biocompatible polymers, have gained attention in recent decades. We invite researchers to provide original research articles, as well as review articles, focusing on multiple issues about the design of original drug release and vaccine delivery systems, possibly revealing novel design technologies and biomaterials for drug delivery, including their obtainment, characterization, structure, original aspects, advantages, disadvantages, and various medical applications.

We look forward to receiving your contributions. 

Dr. Maria Bogdan
Prof. Dr. Liliana Mititelu-Tartau
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • biomaterials
  • biocompatible polymers
  • biocompatibility evaluation
  • drug delivery
  • vaccines
  • nanoparticles
  • structure–property relationship
  • bio-hybrid
  • in vitro and in vivo studies
  • medical applications of biomaterials

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Published Papers

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Pharmaceutics - ISSN 1999-4923